By inhibiting key signaling pathways, such as NF-κB and RIPK1-mediated necroptosis, A20 plays a role in maintaining liver homeostasis and prevents the transition from chronic inflammation to cancer (Figure 2). This evidence concerns the gene NFKB1 and cancer.